Hospital or health organisation · founded 1876
The University of Texas MD Anderson Cancer Center
Houston, United States · mdanderson.org
- Citations, last 5 years
- 470.2k
- Works, last 5 years
- 44.3k
- h-index
- 1,800
- Scientists listed
- 5 302
- Grants since 2016
- 2 323
Grants received
2022 · career development · Young Investigator Award
Targeting AML cells with the novel combination of endogenous T-cell therapy and BCL-2 inhibition
Kapil Saxena · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2022 · career development · Young Investigator Award
CD38 as a Targetable Antigen in Large B Cell Lymphoma (LBCL) to improve the efficacy CD19 Directed Chimeric Antigen Receptor T (CAR T) Cell Therapy and Mitigate CD19 Negative Relapse
Patrick Reville · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2022 · fellowship · AACR-Pfizer Breast Cancer Research Fellowship
Single Cell Genomic Evolution of HER2-Resistance in Breast Cancer
Zhenna Xiao · The University of Texas MD Anderson Cancer Center · funded by American Association for Cancer Research
2022 · career development · Young Investigator Award
Landscape of the immune microenvironment in HPV-related oropharynx squamous cell carcinoma and its impact on outcomes following chemoradiotherapy (CRT)
Luana Guimaraes De Sousa · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2022 · career development · Young Investigator Award
Imaging Activation of Innate Myeloid Immunity in CAR T-Cell-Associated Neurotoxicity Using [18F]4FN PET Imaging
Ajlan Al Zaki · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2022 · career development · Young Investigator Award
Prediction of Treatment Failure Following CD19 CAR T-cell Therapy in Large B-Cell Lymphoma by Measurement of Circulating Tumor DNA
Hua-Jay Cherng · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2022 · training · HIP Fellow Award
HIP Fellow Award 2022: Chijioke Nze
Chijioke Nze · The University of Texas MD Anderson Cancer Center · funded by American Society of Hematology
2022 · training · HIP Fellow Award
HIP Fellow Award 2022: Owhofasa Agbedia
Owhofasa Agbedia · The University of Texas MD Anderson Cancer Center · funded by American Society of Hematology
2022 · career development · Young Investigator Award
Needs Assessment to Inform Local Strategy to Enhance Minority Clinical Trial Participation
Chijioke Nze · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2022 · fellowship · AACR-AstraZeneca START Grants
Unraveling the mechanism of DPY30 in pancreatic cancer
Francesca Citron · The University of Texas MD Anderson Cancer Center · funded by American Association for Cancer Research
2022 · career development · Young Investigator Award
Clinicopathological and Molecular Predictors of Brain Metastases in Clinically Localized Melanoma
Merve Hasanov · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2022–2027 · research · SU2C CATALYST® RESEARCH TEAM GRANT PROGRAM WITH SUPPORT FROM MIRATI THERAPEUTICS
Targeting Adaptive and Acquired Resistance to Direct KRAS Inhibition
Ryan B. Corcoran · The University of Texas MD Anderson Cancer Center · funded by Stand Up To Cancer
2022 · career development · Career Development Award
Targeting the Folate and Adenosine Pathways to Enhance Anti-Cancer Immunity In MTAP-Deficient Urothelial Cancer
Omar Alhalabi · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2022 · career development · Young Investigator Award
Targeting aggressive NK-cell leukemia and other CD94-expressing NK/T-cell lymphoproliferative disorders with anti-CD94 CAR T-cell therapy
Owhofasa Agbedia · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2022 · career development · Young Investigator Award
Detecting and Intervening on Rare Pre-Existing Resistant Subclones to BRAF/MEK Inhibitors in Non-Uveal Melanoma
Michael Nakazawa · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2022–2027 · career development · K08
Skin Cancer Risks and Risk Prediction in Patients with Actinic Keratosis
Mackenzie Rachel Wehner · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
Promoting remyelination in multiple sclerosis by simultaneously modulating myelin debris clearance and myelin lipid synthesis
Jian Hu · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2026 · research · R01
Analgesic Signaling in Drosophila
Michael J Galko · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · research · R37
Role of the pro-inflammatory omental microenvironment in ovarian cancer progression
Chi Lam Au Yeung · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · cooperative agreement · U01
Spatial and temporal tumor-immune co-evolution and interactions that model lung adenocarcinoma development
Humam Kadara · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
Role of Heat Shock Protein 70 as a Mediator and Therapeutic Target in T-cell Lymphomas
Javeed Iqbal · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2026 · research · R01
Analyzing Adhesion and Signaling Functions for PTPN12 in Invasive Glioma Cells
Joseph H Mccarty · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
Harnessing the nervous system to overcome resistance to immunotherapy in oral cancer
Moran Amit · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
Tumor cell lineage diversity and composition in gastric cancer progression and therapy resistance
Pawel K. Mazur · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
Preclinical optimization of ultra-high dose rate (FLASH) radiotherapy parameters for translational relevance
Emil Schueler · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
Pre-IND Development of Polymeric Micelles with Dual Drug Payloads for HCC Therapy
Diana S-L. Chow · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2028 · research · R01
Imaging-based tumor forecasting to predict brain tumor progression and response to therapy
Christopher Chad Quarles · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
Identification and assessment of unconventional tumor-associated antigens as potential targets for cytotoxic T-cell based immunotherapy of cancer
Patrick Hwu · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
DIRAS3 disrupts K-RAS clustering and signaling, enhancing autophagy and response to autophagy inhibition
Robert C Bast · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
Personalized Risk Prediction to Reduce Cardiovascular Disease in Childhood Cancer Survivors
Rebecca Maureen Howell · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · cooperative agreement · U24
Coordinating and Data Management Center for Translational and Basic Science Research in Early Lesions
Liang Li · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · research · R37
Optimizing Personalized Screening and Diagnostic Decisions for Lung Cancer Based on Dynamic Risk Assessment and Life Expectancy
Iakovos Toumazis · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
Targeting head and neck cancer cells and the adverse tumor microenvironment with a novel small-molecule STAT3 inhibitor
Andrew Sikora · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
Elucidating the evolution of Krt8+ alveolar cells to Kras-mutant lung preneoplasia and cancer
Humam Kadara · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · research · R37
Targeting Acquired Resistance in KRAS Driven Cancers
Wantong Yao · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
A Comprehensive Clinical fMRI Software Solution to Enable Mapping of Critical Functional Networks and Cerebrovascular Reactivity in the Brain
Catherine L Elsinger · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · cooperative agreement · U54
Acquired Resistance to Therapy and Iron (ARTI) Center
Boyi Gan · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
Metabolic basis of ARID1A-mutated ovarian cancer
Rugang Zhang · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
BAF complex deregulation in lymphoma
Michael Richard Green · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
Exploring the Function of MHC-II/Lag3 Axis in Brain Metastasis to Develop Novel Therapeutic Strategies
Dihua Yu · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
